Skip to main content

Table 5 Description and comparison of ORRs of clinical symptoms between the IFNα1b group and the control group after 7 days of treatment

From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial

Group

n

ORR

Control group

80

66.66 ± 36.29

IFNα1b group

67

77.93 ± 22.35

P

 

0.044

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us